Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Condition(s):Polycystic Ovary SyndromeLast Updated:November 2, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Polycystic Ovary SyndromeLast Updated:November 2, 2023Recruiting
Condition(s):Transgenderism; Clotting DisorderLast Updated:December 21, 2022Terminated
Condition(s):Estrogen Levels Among Breast Cancer PatientsLast Updated:February 10, 2022Completed
Condition(s):Emotion Regulation; EstradiolLast Updated:March 15, 2024Completed
Condition(s):Gender DysphoriaLast Updated:July 27, 2023Terminated
Condition(s):Diabetes Type 2; DementiaLast Updated:September 27, 2022Completed
Condition(s):InfertilityLast Updated:February 7, 2019Unknown status
Condition(s):Metastatic Breast CancerLast Updated:March 13, 2024Not yet recruiting
Condition(s):HIV Infection; Vaginal Atrophy; Menopause; Menopause Related Conditions; Aging; Premature Aging; Atrophic Vaginitis; Dysbiosis; VaginitisLast Updated:February 2, 2024Completed
Condition(s):Sexual Dysfunction, PhysiologicalLast Updated:June 2, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.